Yüklüyor......
Basis for molecular diagnostics and immunotherapy for esophageal cancer
INTRODUCTION: Esophageal cancer is an extremely aggressive neoplasm, diagnosed in about 17,000 Americans every year with a mortality rate of more than 80% within five years and a median overall survival of just 13 months. For decades, the go-to regimen for esophageal cancer patients has been the use...
Kaydedildi:
| Yayımlandı: | Expert Rev Anticancer Ther |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5542819/ https://ncbi.nlm.nih.gov/pubmed/27838937 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14737140.2017.1260449 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|